https://www.selleckchem.com/GSK-3.html
By using plerixafor for mobilization, we achieved the target CD34 cell dose of ≥2 × 10 /kg per recipient body weight in all cases with unfavorable D/R ratio. It was observed that 17.4% of cases that not reached the established target cell dose were located in the standard or high-dose mobilization regimes. This difference is even greater for optimal collections (≥5 × 10 /kg), since of the 54.3% cases that did not reach this goal none was mobilized by plerixafor. Tailoring the mobilization regime we can reach the target cell dose, even in those cas
Like
Comment
Share
